MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2026 Earnings Call Transcript May 15, 2026
MiNK Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.57, expectations were $-0.77.
Operator: [Audio Gap] and thank you for joining us today. Over the past several weeks, we’ve presented data at 4 major international scientific meetings beginning with findings in pulmonary fibrosis is a keystone symposium in February, followed by a presentation of our Phase II clinical data in refractory...
